Hi all,
Hope everyone is doing as well as they can.
Just wanted to share the news that Mirvetuximab has been approved for platinum resistant ovarian cancer.
Findings from a phase 3 trial have supported the approval and FDA has granted accelerated approval.
There is so much more in the research pipeline with hundreds of phase 1/2 trials taking place with many new promising treatments.
Regards,
Roman